Abstract: Introduction: Good health education among patients and health professionals with updated preventive vaccination for myocarditis can improve the survival outcome. In addition to this, Knowing the indications of ECMO in case of resuscitation with a good installation in an appropriate timing will prevent multiple organ failure and lead to rapid recovery with short duration use of Extracorporeal Life Support, this case report is rare and there is just a few cases reported in 2013 and we do an improvement in our management. Case presentation: A 49 year-old-woman without known heart disease was referred to our university hospital emergency department after 3 days of Influenza symptoms. At her arrival, rapid-onset cardiogenic shock with normal left ventricular size,diffuse left ventricular hypokinesia, and an ejection fraction of 5% are confirmed by Trans-thoracic echocardiography. Coronary angiography was normal. Echocardiography shows no valves abnormality. However, the patient gets in cardiorespiratory arrest. So, an external cardiac massage was performed then an Extracorporeal Life Support was required. A nasal swap at the admission was positive for influenza type B virus. All other respiratory, blood and urine cultures were negative. On day 8, a repeated Trans-thoracic echocardiography demonstrated significant recovery of left ventricular function with ejection fraction of 20%. Then, full recovery on day 12 with ejection fraction of 50%. Conclusions: Influenza type B infection can cause a fulminant cardiomyopathy without preexisting cardiac disease which can leads to refractory cardiogenic shock. ECMO is a suitable choice for fulminant myocarditis.
Introduction
Influenza, is an infectious disease caused by the influenza virus. It's a common febrile illness during winter. Myocarditis mostly caused by Coxackie B virus, influenza viruses, and echoviruses and it's a self-restricting ending with full recovery, but in the other hand can leads to heart failure [1] . The incidence of myocarditis differs between influenza A (1.3%), B (0.7%) and C (3.6%) virus infections [2] . Fulminant myocarditis (FM) usually following a flu-like illness characterized by sudden onset of severe congestive heart failure or cardiogenic shock [1] . Diagnosis should exclude coronary arteries and acute valvular diseases [2] . The clinical manifestations of viral myocarditis are varying greatly from asymptomatic electrocardiogram (ECG) to severe heart failure [3] .
We report a notable case of profound cardiogenic shock of 49 year old female due to influenza virus type B leaded to FMwith no known pre-existing heart disease. She was successfully managed with Extracorporeal Life Support (ECL).
Case Report
A 49 year-old-woman without known heart disease, presented in the emergency room (ER) with profound cardiogenic shock. The past 3 days prior to admission she had fever, shivering, chills, diffuse myalgia, nausea and vomiting, diagnosed by her doctor as an influenza. The following days, she had a severe chest and epigastric pain associated with many vomiting episodes. A very low blood pressure (BP) (60/40 mmHg) even after a 2L of intravenous (IV) fluid injection for hemodynamic resuscitation justified her admission in intensive care unit (ICU), associated to an impaired level of consciousness, fever, mottled skin and sinus tachycardia without a radial pulse.The ECG revealed an accelerated sinus rhythm with a rate of 140 beats/min, with diffuse low voltage. Arterial blood gas (ABG) showed a severe metabolic acidosis with 7.14 PH, Lactate 7.8, HCO 3 8 and anuria. Examination revealed: A bilateral lung crepitation, and a benign abdomen. On emergent TEE left ventricular (LV) function was severely depressed witha normal dimension and global hypokinesia, an estimated left ventricular ejection fraction (LVEF) of 5%with a cardiac index (CI) of 1.7 L/min/m2, justifying an emergent coronarography which showed normal coronary arteries ( Figure 2 ) and severe LV impairment. 
Discussion
The Influenza is a contagious disease caused by influenza viruses. It can cause mild to severe illness and sometimes can lead to death. So, getting the seasonal vaccination is the single best way to prevent this disease and its epidemic spreading. The Complications of influenza may include pneumonia, sinus infections, and worsening of chronic disease such as pulmonary failure, asthma or diabetes [4] .
Our patient has influenza type B/Yamagata virus that had been diagnosed by a nasal swab at the day of admission. In line with the new recommendations issued by The World Health Organization (WHO) 2015/2016, they added a new strain of influenza B to the trivalent vaccine [5] .WHO recommends early vaccination, several weeks before seasonal influenza outbreaks, for those aged over than 65 and health Professionals [4] .
FM can be differentiated from acute myocarditis which the clinical presentations are different; FM has recent influenza symptoms with a faster progression to refractory cardiogenic shock in comparison to acute myocarditis which is over several weeks. TTE is currently recommended in the initial diagnostic evaluation of all patients with suspected myocarditis.Major diffuse hypokinesiacame in both types but the typical echocardiographic finding in FMis a dilated ventricle cavity with a hypertrophy walls but in acute myocarditis ventricle cavities are normal. In long term recovery of LV function in FM within days or weeks but in acute myocarditis lead to chronic heart failure [6] .
In our patient, after the cardiopulmonary arrest we start a Cardiopulmonary resuscitation (CPR), then a rapid response by our surgical team for application of a peripheral venoarterial ECLS via left common femoral vein and artery with elective limb reperfusion is successfully done. The day after, an ETT revealed an absence of ventricular ejection with ascending aortic sub valvular blood stagnation. So, conversion decision was decided by the medical-surgical team from a switch of the peripheral ECLS to central ECLS (right subclavian artery-right atrium) with TLVV by left mini thoracotomy with a direct canulation to the LV. Early LV decompression by TLVV can prevent the high LV pressure which can cause sub endocardial ischemia and impairs LV recovery [7] .
Refractory cardiogenic chock secondary to FM is associated with a high mortality rate as high as 75% [8, 9] . A mechanical circulatory support such as a percutaneous ECMO with a cardiopulmonary bypass or ventricular assisted device (VAD) can revert this fulminant course. So, early recognition with an immediate rescue can increase the overall survival rate range of 50-70% by cardiac recovery or even cardiac transplantation [10] . The studies showed that percutaneous ECMO has a higher survival rate than VAD [11] . This due to many advantages of percutaneous ECMO on VAD. First, quicker and easier application preventing the multiple organ failure secondary to haemodynamic deterioration. Secondly, easier to wean off than VAD, and ECMO can be converted to VAD. Third, the support duration to recovery was shorter in ECMO than in VAD [12] [13] . Fourth, daily troponin level was found as a good indicator for myocardial recovery in weaning of ECMO but it cannot be applied in VAD patient [14] . On the other hand, Grinda et al reported 5 consecutive FM patients with intractable cardiogenic shock by using mechanical paracorporel (BiVAD) with a successfully bridged to recovery. They used BiVAD instead of ECMO because of a diffuse biventricular disease in FM,BiVAD will give an efficientunloading of LV witch is important for rapid recovery [15] .
In the future, good health education among patients and health professionals with updated preventive vaccination for myocarditis can improve the survival outcome in similar cases. In addition to this, Knowing the indications of ECMO in case of resucitataion with a good installation in an appropriate timing will prevent multiple organ failure and lead to rapid recovery with short duration use of ECMO.
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